시장보고서
상품코드
1947475

방사선학용 AI 시장 : 제공 제품별, 기능별, 모달리티별, 적응증별, 최종 사용자별 예측(-2036년)

AI for Radiology Market by Offering, Function, Modality, Indication, and End User - Global Forecast to 2036

발행일: | 리서치사: Meticulous Research | 페이지 정보: 영문 262 Pages | 배송안내 : 5-7일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 방사선학용 AI 시장은 예측 기간 중(2026-2036년) CAGR 21.5%로 확대되어 2026년 16억 9,000만 달러에서 2036년까지 약 118억 4,000만 달러에 이를 것으로 전망되고 있습니다.

본 보고서는 5개 주요 지역에서 세계 방사선학용 AI 시장에 대해 현재 시장 동향, 시장 규모, 최근 동향, 2036년까지의 예측에 중점을 두고 상세한 분석을 제공합니다. 광범위한 2차 및 1차 조사 및 시장 시나리오에 대한 상세한 분석을 통해 주요 업계의 촉진요인, 억제요인, 기회 및 과제의 영향 분석을 수행합니다.

방사선학용 AI 시장의 성장을 견인하는 주요 요인으로는 질병 조기 발견에 대한 세계 수요 증가, 의료 기관에 자동 진단 영상 시스템의 급속한 보급, 숙련된 방사선과 의사의 심각한 부족, 진단 오차의 최소화에 대한 요구 등이 있습니다. 게다가 클라우드 기반 인프라의 급속한 확대, 고성능 알고리즘에 대한 수요 증가, AI를 활용한 예측 분석, 멀티모달 AI 시스템, 의료 분야에서의 디지털 전환의 대처 등이 방사선학용 AI 시장에서 사업을 전개하는 기업에게 큰 성장 기회를 창출할 것으로 예측됩니다.

시장 세분화

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

  • 시장 역학
    • 성장 촉진요인
    • 억제요인
    • 기회
    • 과제
  • 멀티 모달 AI 및 기반 모델이 방사선 의학에 미치는 영향
  • 규제 상황(FDA, EU AI법, CE 마킹)
  • Porter's Five Forces 분석

제4장 세계의 방사선학용 AI 시장 : 제공 제품별

  • 소프트웨어 및 SaaS
    • 클라우드 기반 솔루션
    • 하이브리드 도입 모델
  • 온디바이스 소프트웨어
    • 임베디드 AI 솔루션
    • 엣지 컴퓨팅 플랫폼

제5장 세계의 방사선학용 AI 시장 : 기능별

  • 스크리닝 및 트리어지
  • 진단 영상 및 해석
    • 검출 및 분류
    • 정량화 및 측정
  • 치료 계획 및 개입 지원
  • 모니터링 및 경과 관찰
  • 보고 및 문서화
  • 워크플로우 최적화
  • 연구 및 임상개발
  • 기타 기능

제6장 세계의 방사선학용 AI 시장 : 모달리티별

  • 컴퓨터 단층 촬영(CT)
    • 일반 CT
    • 스펙트럼/광자 계수형 CT
  • 자기 공명 영상법(MRI)
  • X선
    • 디지털 라디오그래피
    • 투시 검사
  • 초음파
  • 유방 조영
    • 2D 유방촬영
    • 토모신세시스
  • 기타 모달리티(PET, SPECT, 핵의학)

제7장 세계의 방사선학용 AI 시장 : 적응증별

  • 종양학
    • 폐암
    • 유방암
    • 기타 암
  • 심장병학
    • 관상동맥질환
    • 구조적 심장병
  • 신경학
    • 뇌졸중 및 뇌혈관질환
    • 외상성 뇌 손상
    • 신경퇴행성 질환
  • 호흡기내과/호흡기 질환
    • 폐렴 및 감염증
    • 만성 폐 질환
  • 정형외과
    • 골절 검출
    • 뼈 연령 평가
  • 여성 건강
    • 유방 영상 진단
    • 산과 영상 진단
  • 기타 적응증

제8장 세계의 방사선학용 AI 시장 : 최종 사용자별

  • 병원
    • 대학 병원
    • 지역 병원
  • 진단 영상 센터
  • 기타 최종 사용자(원격 방사선 진단, 연구 기관)

제9장 세계의 방사선학용 AI 시장 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 네덜란드
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 인도
    • 호주
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타 라틴아메리카
  • 중동 및 아프리카

제10장 경쟁 구도

  • 주요 성장 전략
  • 경쟁 벤치마킹
  • 경쟁 대시보드
    • 산업 리더
    • 시장의 차별화 요인
    • 선구기업
    • 신흥기업
  • 주요 기업 시장 랭킹/포지셔닝 분석(2025년)

제11장 기업 프로파일(기기 제조업체 및 AI 솔루션 제공업체)

  • Siemens Healthineers AG
  • GE HealthCare
  • Koninklijke Philips NV
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Hologic, Inc.
  • Aidoc
  • Viz.ai
  • Lunit
  • RapidAI
  • Qure.ai
  • Annalise.ai
  • Rad AI
  • DeepHealth(RadNet, Inc.)
  • Enlitic, Inc.
  • Subtle Medical
  • Cleerly
  • Merative
  • iCAD

제12장 부록

JHS 26.03.05

AI for Radiology Market by Offering (Software/SaaS, On-Device Software), Function (Screening & Triage, Diagnostic Imaging & Interpretation, Treatment Planning & Intervention Support, Monitoring & Follow-Up, Reporting & Documentation, Workflow Optimization), Modality (Computed Tomography, Magnetic Resonance Imaging, X-Ray, Ultrasound, Mammography), Indication, and End User - Global Forecast to 2036

According to the research report titled, 'AI for Radiology Market by Offering (Software/SaaS, On-Device Software), Function (Screening & Triage, Diagnostic Imaging & Interpretation, Treatment Planning & Intervention Support, Monitoring & Follow-Up, Reporting & Documentation, Workflow Optimization), Modality (Computed Tomography, Magnetic Resonance Imaging, X-Ray, Ultrasound, Mammography), Indication, and End User - Global Forecast to 2036,' the global AI for radiology market is expected to reach approximately USD 11.84 billion by 2036 from USD 1.69 billion in 2026, at a CAGR of 21.5% during the forecast period (2026-2036).

The report provides an in-depth analysis of the global AI for radiology market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.

The major factors driving the growth of the AI for radiology market include the intensifying global demand for early disease detection, rapid expansion of automated diagnostic imaging systems across healthcare institutions, critical shortage of skilled radiologists, and the need to minimize diagnostic errors. Additionally, the rapid expansion of cloud-based infrastructure, increasing need for high-performance algorithms, AI-powered predictive analytics, multimodal AI systems, and digital transformation initiatives in healthcare are expected to create significant growth opportunities for players operating in the AI for radiology market.

Market Segmentation

The AI for radiology market is segmented by offering (software/SaaS, on-device software), function (screening & triage, diagnostic imaging & interpretation, treatment planning & intervention support, monitoring & follow-up, reporting & documentation, workflow optimization), modality (computed tomography, magnetic resonance imaging, X-ray, ultrasound, mammography), indication (oncology, neurology, cardiology, orthopedics, others), end user (hospitals, diagnostic imaging centers, ambulatory surgery centers), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Offering

By offering, the software/SaaS segment holds the largest market share in 2026, primarily attributed to its scalable deployment model in supporting rapid implementation and seamless integration within existing healthcare IT environments, such as in large hospital networks and multi-site imaging centers. These systems offer the most comprehensive way to ensure diagnostic consistency across diverse high-volume clinical applications. Software/SaaS solutions are utilized extensively in enterprise healthcare and cloud computing sectors. However, the on-device software segment maintains a significant share due to the growing need for low-latency processing in time-critical diagnostic applications, particularly in emergency departments and stroke centers. The ability to provide instant analysis without cloud connectivity makes on-device software highly attractive for specialized clinical environments.

Based on Function

By function, diagnostic imaging & interpretation segment holds the largest share of the overall market in 2026, driven by the need for comprehensive AI-enabled analysis across diverse imaging modalities. Screening & triage functions represent significant applications for rapid patient prioritization and workflow optimization. Treatment planning & intervention support, monitoring & follow-up, and reporting & documentation represent emerging functions with growing adoption. Workflow optimization functions are expected to witness rapid growth during the forecast period, driven by the growing need for operational efficiency and reduced radiologist burnout. The ability to automate routine tasks and enhance clinical productivity makes workflow optimization highly attractive for healthcare institutions.

Based on Modality

By modality, the computed tomography segment holds the largest share of the overall market in 2026, primarily due to the massive volume of CT procedures performed globally and the rigorous performance standards required for modern diagnostic imaging. Current large-scale healthcare facilities are increasingly specifying AI-enhanced CT solutions to ensure compliance with clinical protocols. Magnetic resonance imaging segment is expected to witness rapid growth during the forecast period, driven by the shift toward integrated diagnostic platforms and the complexity of MRI interpretation workflows. X-ray, ultrasound, and mammography represent significant segments with distinct AI application requirements and clinical workflows.

Based on Indication

By indication, the oncology segment is expected to grow at the fastest CAGR during the forecast period. This rapid expansion stems from the critical need for early cancer detection and the massive global cancer burden requiring advanced diagnostic capabilities. The increasing emphasis on precision oncology and personalized treatment planning is driving demand for AI systems that can identify subtle imaging biomarkers. Neurology segment commands substantial market share in 2026, fueled by expanding applications in stroke detection, traumatic brain injury assessment, and neurodegenerative disease monitoring. Cardiology, orthopedics, and other indications represent specialized segments with distinct diagnostic requirements and clinical applications.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. In 2026, North America dominates the global AI for radiology market with the largest market share, primarily attributed to advanced healthcare infrastructure and the presence of leading technology providers in the U.S. and Canada. The United States alone accounts for a significant portion of global AI radiology adoption, with its position as a hub for healthcare innovation driving sustained growth. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by rapidly expanding healthcare infrastructure, increasing medical imaging volumes, and government initiatives promoting AI adoption in healthcare. In Europe, the leadership in regulatory frameworks and the push for healthcare digitalization are driving the adoption of AI-powered radiology systems, with countries like Germany, France, and the United Kingdom leading implementations.

Key Players

The key players operating in the global AI for radiology market are Siemens Healthineers AG (Germany), GE HealthCare (U.S.), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), Shanghai United Imaging Healthcare Co. (China), Hologic, Inc. (U.S.), Merative (U.S.), and emerging AI-native companies such as Aidoc (Israel), Viz.ai (U.S.), Lunit (South Korea), RapidAI (U.S.), Qure.ai (India), Annalise.ai (U.S.), Rad AI (U.S.), DeepHealth (U.S.), Enlitic, Inc. (U.S.), Subtle Medical (U.S.), and Cleerly (U.S.), among others.

Key Questions Answered in the Report

  • What is the current revenue generated by the AI for radiology market globally?
  • At what rate is the global AI for radiology market demand projected to grow for the next 7-10 years?
  • What are the historical market sizes and growth rates of the global AI for radiology market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of offering, function, modality, and indication are expected to create major traction for the service providers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global AI for radiology market?
  • Who are the major players in the global AI for radiology market? What are their specific service offerings in this market?
  • What are the recent strategic developments in the global AI for radiology market? What are the impacts of these strategic developments on the market?

Scope of the Report:

AI for Radiology Market Assessment -- by Offering

  • Software/SaaS
  • On-Device Software

AI for Radiology Market Assessment -- by Function

  • Screening & Triage
  • Diagnostic Imaging & Interpretation
  • Treatment Planning & Intervention Support
  • Monitoring & Follow-Up
  • Reporting & Documentation
  • Workflow Optimization

AI for Radiology Market Assessment -- by Modality

  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • X-Ray
  • Ultrasound
  • Mammography
  • Other Modalities

AI for Radiology Market Assessment -- by Indication

  • Oncology
  • Neurology
  • Cardiology
  • Orthopedics
  • Other Indications

AI for Radiology Market Assessment -- by End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgery Centers
  • Other End Users

AI for Radiology Market Assessment -- by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Southeast Asia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Scope
  • 1.3. Research Methodology
  • 1.4. Assumptions & Limitations

2. Executive Summary

3. Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
    • 3.2.4. Challenges
  • 3.3. Impact of Multimodal AI and Foundation Models on Radiology
  • 3.4. Regulatory Landscape (FDA, EU AI Act, CE Marking)
  • 3.5. Porter's Five Forces Analysis

4. Global AI for Radiology Market, by Offering

  • 4.1. Introduction
  • 4.2. Software/SaaS
    • 4.2.1. Cloud-Based Solutions
    • 4.2.2. Hybrid Deployment Models
  • 4.3. On-Device Software
    • 4.3.1. Embedded AI Solutions
    • 4.3.2. Edge Computing Platforms

5. Global AI for Radiology Market, by Function

  • 5.1. Introduction
  • 5.2. Screening & Triage
  • 5.3. Diagnostic Imaging & Interpretation
    • 5.3.1. Detection & Classification
    • 5.3.2. Quantification & Measurement
  • 5.4. Treatment Planning & Intervention Support
  • 5.5. Monitoring & Follow-Up
  • 5.6. Reporting & Documentation
  • 5.7. Workflow Optimization
  • 5.8. Research & Clinical Development
  • 5.9. Other Functions

6. Global AI for Radiology Market, by Modality

  • 6.1. Introduction
  • 6.2. Computed Tomography (CT)
    • 6.2.1. General CT
    • 6.2.2. Spectral/Photon-Counting CT
  • 6.3. Magnetic Resonance Imaging (MRI)
  • 6.4. X-Ray
    • 6.4.1. Digital Radiography
    • 6.4.2. Fluoroscopy
  • 6.5. Ultrasound
  • 6.6. Mammography
    • 6.6.1. 2D Mammography
    • 6.6.2. Tomosynthesis
  • 6.7. Other Modalities (PET, SPECT, Nuclear Medicine)

7. Global AI for Radiology Market, by Indication

  • 7.1. Introduction
  • 7.2. Oncology
    • 7.2.1. Lung Cancer
    • 7.2.2. Breast Cancer
    • 7.2.3. Other Cancers
  • 7.3. Cardiology
    • 7.3.1. Coronary Artery Disease
    • 7.3.2. Structural Heart Disease
  • 7.4. Neurology
    • 7.4.1. Stroke & Cerebrovascular Disease
    • 7.4.2. Traumatic Brain Injury
    • 7.4.3. Neurodegenerative Diseases
  • 7.5. Pulmonology/Respiratory Diseases
    • 7.5.1. Pneumonia & Infections
    • 7.5.2. Chronic Lung Diseases
  • 7.6. Orthopedics
    • 7.6.1. Fracture Detection
    • 7.6.2. Bone Age Assessment
  • 7.7. Women's Health
    • 7.7.1. Breast Imaging
    • 7.7.2. Obstetric Imaging
  • 7.8. Other Indications

8. Global AI for Radiology Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals
    • 8.2.1. Academic Medical Centers
    • 8.2.2. Community Hospitals
  • 8.3. Diagnostic Imaging Centers
  • 8.4. Other End Users (Teleradiology, Research Institutions)

9. Global AI for Radiology Market, by Region

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Netherlands
    • 9.3.7. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. South Korea
    • 9.4.4. India
    • 9.4.5. Australia
    • 9.4.6. Rest of Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America
  • 9.6. Middle East & Africa

10. Competitive Landscape

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Ranking/Positioning Analysis of Key Players, 2025

11. Company Profiles (Equipment Manufacturers & AI Solution Providers)

  • 11.1. Siemens Healthineers AG
  • 11.2. GE HealthCare
  • 11.3. Koninklijke Philips N.V.
  • 11.4. Canon Medical Systems Corporation
  • 11.5. Fujifilm Holdings Corporation
  • 11.6. Shanghai United Imaging Healthcare Co., Ltd.
  • 11.7. Hologic, Inc.
  • 11.8. Aidoc
  • 11.9. Viz.ai
  • 11.10. Lunit
  • 11.11. RapidAI
  • 11.12. Qure.ai
  • 11.13. Annalise.ai
  • 11.14. Rad AI
  • 11.15. DeepHealth (RadNet, Inc.)
  • 11.16. Enlitic, Inc.
  • 11.17. Subtle Medical
  • 11.18. Cleerly
  • 11.19. Merative
  • 11.20. iCAD

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Related Reports
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제